The abstract is read at the publisher; the summary is JClub's.
Germline heterozygous loss-of-function variants in MDM4 in 6 individuals are linked to p53-mediated bone marrow failure, with hypocellular MDS and variable onset.
- Why it matters: Bone marrow failure syndromes are heterogeneous and can progress to MDS and leukemia, but the specific MDM4-driven mechanism and hematopoietic consequences were unclear.
- What they did: The study combined genomic analysis, CRISPR/Cas9 deletion of MDM4 in healthy donor HSPCs, and patient-specific iPSC modeling, measuring p53 activity, colony formation, engraftment, and p21 expression.
- The result: MDM4-haploinsufficient HSPCs showed increased p53 activity, impaired colony-forming capacity, and reduced engraftment in immunodeficient mice, while MDM4-mutant iPSCs produced fewer erythroid and myeloid cells with elevated p21 and p53-pathway upregulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.